# ADENTRA Inc. (ADEN.TO) fundamentals

Data as of 2026-11-04. TSX, Canada. Sector: Industrials / Industrial Distribution & Rental. Price C$37.16, market value C$901 million.

## Valuation
- **P/E (trailing): 10.1×** (5-yr avg 13.7×, 3-yr avg 16.7×). ADENTRA Inc. trades at 10.1× trailing earnings, well below its own five-year average of 13.7×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 8.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.21**. A PEG of 0.21 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 7.5×**. Enterprise value is 7.5× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 16.0%** (5-yr avg 24.8%). Free cash flow equals 16.0% of the market value, below its five-year average of 24.8%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 9.9%**. The inverse of the P/E: 9.9% of the price is earned each year.

## Profitability
- **Gross margin: 21.4%**. ADENTRA Inc. keeps 21.4% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 4.4%**. 4.4% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 3.0%**. 3.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.2%**. 10.2% on shareholders' equity is solid.
- **Return on invested capital: 8.1%**. Return on all capital, debt included, is 8.1%.
- **Return on assets: 4.9%**. Each dollar of assets produces 4.9% of profit.

## Growth
- **Revenue growth (1 yr): 3.0%** (3-yr -4.5%/yr). Revenue grew 3.0% over the last year.
- **EPS growth (1 yr): 41.1%** (3-yr -20.9%/yr). Earnings per share rose 41.1%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -9.9%/yr**. Free cash flow has compounded at -9.9% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.86**. Debt is 0.86 times equity, moderate leverage.
- **Net debt / EBITDA: 2.9×**. It would take 2.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 2.4×**. Operating profit covers interest 2.4×, thin but manageable.
- **Current ratio: 2.05** (quick 0.72). Current assets cover the next year's liabilities 2.05 times.
- **Altman Z-score: 3.57**. A Z-score of 3.57 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 1.72%** (C$0.64 per share, trailing). ADENTRA Inc. yields 1.72%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 16%** (8% of free cash flow). 16% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 10**. 10 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 12.0%/yr** (1-yr 7.1%). The dividend has compounded at 12.0% a year over five years, doubling roughly every 6 years at that pace.
- **Shareholder yield: 3.1%**. Dividends plus net buybacks return 3.1% of the market value a year.

## Analyst view
- **Analyst consensus: buy** (9 analysts). 9 analysts cover ADENTRA Inc.; the consensus is buy, with an average price target of C$49.23 (+32% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 6.0%** (YTD 6.5%, 3-mo 2.9%). The shares are up 6.0% over twelve months including dividends.
- **From 52-week high: -9.8%** (18.3% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 0.74** (volatility 31%). Beta of 0.74 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ADEN.TO · Page: https://foliofundamentals.com/stocks/aden.to

Not investment advice.